Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
Reversão do bloqueio neuromuscular com sugamadex em cinco receptores pediátricos de transplante cardíaco
Ricardo Vieira Carlos; Marcelo Luis Abramides Torres; Hans Donald de Boer
Abstract
Keywords
Resumo
Palavras-chave
References
Anesthesia for cardiac surgical procedures. 2015:2007-295.
Arbous MS, Meursing AEE, van Kleef JW. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology. 2005;102:257-68.
Murphy GS, Szokol JW, Marymont JH. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130-7.
Grosse-Sundrup M, Henneman JP, Sandberg WS. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ. 2012;345:e6329.
Barbara DW, Christensen JM, Mauermann WJ. The safety of neuromuscular block reversal in patients with cardiac transplantation. Transplantation. 2016;100:2723-8.
Bertolizio G, Yuki K, Odegard K. Cardiac arrest and neuromuscular blockade reversal agents in the transplanted heart. J Cardiothorac Anesth. 2013;27:1374-8.
Beebe DS, Shumway SJ, Maddock R. Sinus arrest after intravenous neostigmine in two heart transplant recipients. Anesth Analg. 1994;78:779-82.
Bjerke RJ, Mangione MP. Asystole after intravenous neostigmine in a heart transplant recipient. Can J Anaesth. 2001;48:305-7.
Sawasdiwipachai P, Laussen PC, McGowan FX. Cardiac arrest after neuromuscular blockade reversal in heart transplant infant. Anesthesiology. 2007;107:663-5.
Gomez-Rios MA, Lopez LR. Use of combination of rocuronium and sugammadex in heart transplant recipients. Anaesth Intensive Care. 2012;40:903-4.
Tezcan B, Saylan A, Bolukbasi D. Use of sugammadex in a heart transplant recipient: review of the unique physiology of the transplanted heart. J Cardiothorac Anesth. 2016;30:462-5.
Fuchs-Buder T, Claudius C, Skovgaard LT. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007;51:789-808.
Backman SB, Fox GS, Stein RD. Neostigmine decreases heart rate in heart transplant patients. Can J Anaesth. 1996;43:373-8.
Dahl V, Pendeville PE, Hollmann MW. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. Eur J Anaesthesiol. 2009;26:874-84.
De Kam PJ, van Kuijk J, Prohn M. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough study. Clin Drug Investig. 2010;30:599-611.
De Kam PJ, van Kuijk J, Smeets J. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study. Int J Clin Pharmacol Ther. 2012;50:595-604.